176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.32%
Net income growth under 50% of MRVL's 69.03%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-13.07%
Both reduce yoy D&A, with MRVL at -75.47%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
99.71%
Deferred tax of 99.71% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-142.86%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-76.34%
Both reduce yoy usage, with MRVL at -46.02%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
90.15%
AR growth of 90.15% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
56.90%
Inventory growth well above MRVL's 7.54%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-116.69%
Negative yoy AP while MRVL is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
138.39%
Some yoy usage while MRVL is negative at -49.20%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-77.09%
Negative yoy while MRVL is 100.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
2.58%
Some CFO growth while MRVL is negative at -68.56%. John Neff would note a short-term liquidity lead over the competitor.
74.85%
Some CapEx rise while MRVL is negative at -9.76%. John Neff would see competitor possibly building capacity while we hold back expansions.
-106.21%
Negative yoy acquisition while MRVL stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
27.20%
Less growth in investment purchases vs. MRVL's 74.55%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
226.86%
Proceeds from sales/maturities above 1.5x MRVL's 42.56%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-8060.00%
We reduce yoy other investing while MRVL is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
44.85%
Investing outflow well above MRVL's 77.38%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-69.47%
Both yoy lines negative, with MRVL at -56.84%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.